The effect of healing on bile reflux in gastric ulcer.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMC 1411867)

Published in Gut on July 01, 1971

Authors

R B Black, G Roberts, J Rhodes

Articles citing this

Surgical management of reflux gastritis. Ann Surg (1974) 1.60

Measurement of bile acids in fasting gastric aspirates: an objective test for bile reflux after gastric surgery. Gut (1978) 1.29

Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut (1983) 1.25

Symptomatic significance of gastric mucosal changes after surgery for peptic ulcer. Gut (1977) 1.24

Healthy controls have as much bile reflux as gastric ulcer patients. Gut (1987) 1.17

Duodenogastric reflux: a cause of gastric mucosal hyperaemia and symptoms after operations for peptic ulceration. Gut (1975) 1.17

Aspects of duodeno-gastric reflux in man. Gut (1972) 1.11

Management of postoperative alkaline reflux gastritis. Ann Surg (1973) 1.04

Mechanism by which bile salt disrupts the gastric mucosal barrier in the dog. J Clin Invest (1980) 0.95

Effect of cigarette smoking on competence of the pylorus: preliminary study. Br Med J (1973) 0.95

Measurement of total bile acids in gastric juice. J Clin Pathol (1984) 0.85

Pyloric reflux and the healing of gastric ulcers. Gut (1973) 0.83

Enterogastric reflux and gastric clearance of refluxate in normal subjects and in patients with and without bile vomiting following peptic ulcer surgery. Ann Surg (1986) 0.83

Duodenogastric reflux: is there any progress? Br Med J (Clin Res Ed) (1982) 0.81

Lithium fluxes across the gastric mucosa after truncal vagotomy and drainage--an objective assessment of mucosal injury. Gut (1986) 0.75

Articles cited by this

ENZYMATIC DETERMINATION AND THIN-LAYER CHROMATOGRAPHY OF BILE ACIDS IN BLOOD. J Biochem (1964) 3.61

PATHOGENESIS OF GASTRIC ULCERATION. Lancet (1965) 3.34

EFFECT OF DUODENAL CONTENTS ON THE GASTRIC MUCOSA UNDER EXPERIMENTAL CONDITIONS. Lancet (1964) 3.30

Detergent properties of bile salts: correlation with physiological function. Annu Rev Med (1967) 3.25

Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology (1968) 2.99

Factors in the pathogenesis of gastric ulcer. Hunterian lecture delivered at the Royal College of Surgeons of England on 18th January 1966. Ann R Coll Surg Engl (1967) 2.96

Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86

PLASMA BILIRUBIN DETERMINATION IN THE NEWBORN INFANT. A METHODOLOGICAL STUDY WITH SPECIAL REFERENCE TO THE INFLUENCE OF HEMOLYSIS. Pediatrics (1965) 2.71

A study of the changes in pH of gastric contents in peptic ulcer using the twenty-four hour test meal. Gastroenterology (1951) 2.61

Some aspects of the pathogenesis and surgical management of peptic ulcers. S Afr Med J (1960) 1.66

The quantitative determination of bile salts in bile using thin-layer chromatography and 3 alpha-hydroxysteroid dehydrogenase. Clin Chim Acta (1969) 1.46

Steroids in human blood. Vitam Horm (1957) 1.09

Antral motility in patients with gastric ulcer. Am J Dig Dis (1966) 1.04

The proper study. Gastroenterology (1970) 0.84

Experimental gastric ulcers in the rat: the separate and combined effects of vagotomy and bile-duct implantation into the stomach. Br J Surg (1970) 0.83

Articles by these authors

Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08

An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49

Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35

Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08

Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90

Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86

Timing and purpose of the MRCGP examination. J R Coll Gen Pract (1989) 2.84

Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75

Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67

Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67

Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32

Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren. Lancet (1988) 2.31

Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol (1999) 2.26

The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23

Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21

Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07

Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05

Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04

Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03

The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02

Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95

The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy (2007) 1.91

Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88

Risk-adjusted analysis of surgeon performance: a 1-year study. Br J Surg (1995) 1.81

EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy (2014) 1.80

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

Comments on Oxoid Signal blood culture system. J Clin Pathol (1987) 1.78

Altered bowel habit and menstruation. Lancet (1976) 1.73

Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73

Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71

Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69

Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67

An explanatory model of health promotion and quality of life in chronic disabling conditions. Nurs Res (2000) 1.66

Mortality in Crohn's disease. Q J Med (1980) 1.62

Radiotherapy service delivery models for a dispersed patient population. Clin Oncol (R Coll Radiol) (2001) 1.61

Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.60

Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60

Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59

Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57

pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57

The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum (1994) 1.57

[Not Available]. BioDrugs (1997) 1.56

Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56

Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55

Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy (2014) 1.55

Sexual selection and the evolution of evolvability. Heredity (Edinb) (2006) 1.54

Complications of carbenoxolone therapy. Br Med J (1974) 1.54

Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol (1998) 1.51

A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol (1993) 1.50

Evolutionary implications of phenotypic plasticity in the hindlimb of the lizard Anolis sagrei. Evolution (2000) 1.46

The management of stab wounds of the abdomen and thorax. Br J Surg (1966) 1.46

Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46

Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44

Phototherapy of human tumours using haematoporphyrin derivative. Med J Aust (1980) 1.44

Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42

Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41

Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41

Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40

Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40

Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40

Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40

Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39

Aggressive approach in the treatment of acute lead encephalopathy with an extraordinarily high concentration of lead. Arch Pediatr Adolesc Med (1998) 1.38

Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37

Etiology of gastric ulcer. Gastroenterology (1972) 1.37

Prey scan at random to evade observant predators. Proc Biol Sci (2001) 1.36

Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36

Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36

'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33

Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29

Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29

Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29

Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29

Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods. Pediatr Cardiol (2000) 1.28

Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27

Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26

Improved methods for reducing calcium and magnesium concentrations in tissue culture medium: application to studies of lymphoblast proliferation in vitro. In Vitro (1976) 1.26

The epidemiology of anaphylaxis in Europe: a systematic review. Allergy (2013) 1.26

An analysis of a melanoma epidemic. Int J Cancer (1993) 1.25

Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy (2004) 1.25

Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23

Adherence discourse among African-American women taking HAART. AIDS Care (2002) 1.22

5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis. J Pharm Pharmacol (1983) 1.22

Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Br Med J (Clin Res Ed) (1983) 1.21

Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20

A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab (1974) 1.20

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. Gut (1987) 1.20

Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br J Clin Pharmacol (1984) 1.19

Flavobacterium meningosepticum in the hospital environment. J Clin Pathol (1976) 1.19

The evolution of generosity and choosiness in cooperative exchanges. J Theor Biol (1998) 1.19

Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19

Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol (1985) (2004) 1.19

Polarity in the glnA operon: suppression of the reg- phenotype by rho mutations. J Bacteriol (1982) 1.18

Coarse mucosal folds in the duodenum. Q J Med (1968) 1.18

Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17